DK258789D0 - Peptider, der blokerer bindingen af hiv-1 til cd4 receptorproteinet - Google Patents

Peptider, der blokerer bindingen af hiv-1 til cd4 receptorproteinet

Info

Publication number
DK258789D0
DK258789D0 DK258789A DK258789A DK258789D0 DK 258789 D0 DK258789 D0 DK 258789D0 DK 258789 A DK258789 A DK 258789A DK 258789 A DK258789 A DK 258789A DK 258789 D0 DK258789 D0 DK 258789D0
Authority
DK
Denmark
Prior art keywords
hiv
peptides
binding
block
receptor protein
Prior art date
Application number
DK258789A
Other languages
English (en)
Other versions
DK258789A (da
Inventor
Patricia E Rao
Bradford A Jameson
Stephen B H Kent
Original Assignee
Ortho Pharma Corp
California Inst Of Techn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp, California Inst Of Techn filed Critical Ortho Pharma Corp
Publication of DK258789D0 publication Critical patent/DK258789D0/da
Publication of DK258789A publication Critical patent/DK258789A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • C07K14/70514CD4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2812Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK258789A 1988-05-27 1989-05-26 Peptider, der blokerer bindingen af hiv-1 til cd4 receptorproteinet DK258789A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19997388A 1988-05-27 1988-05-27

Publications (2)

Publication Number Publication Date
DK258789D0 true DK258789D0 (da) 1989-05-26
DK258789A DK258789A (da) 1989-11-28

Family

ID=22739793

Family Applications (1)

Application Number Title Priority Date Filing Date
DK258789A DK258789A (da) 1988-05-27 1989-05-26 Peptider, der blokerer bindingen af hiv-1 til cd4 receptorproteinet

Country Status (6)

Country Link
EP (1) EP0344006A3 (da)
JP (1) JPH02131497A (da)
AU (1) AU626865B2 (da)
DK (1) DK258789A (da)
PT (1) PT90657B (da)
ZA (1) ZA894024B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU620107B2 (en) * 1988-05-27 1992-02-13 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Compositions having use as treatment of psoriasis and neuropsychiatric deficits
JPH03254693A (ja) * 1990-03-06 1991-11-13 Calpis Food Ind Co Ltd:The 抗イデオタイプ抗体作製用抗原、抗イデオタイプ抗体、及びその製法
CA2041271A1 (en) * 1990-04-30 1991-10-31 Bradford A. Jameson Peptide analogs to proteins of the immunoglobin superfamily
JPH05262662A (ja) * 1991-07-15 1993-10-12 Calpis Food Ind Co Ltd:The Hiv重感染防止剤、抗イディオタイプ抗体作製用抗原及び抗イディオタイプ抗体の製造法
WO1994000488A1 (en) * 1992-06-23 1994-01-06 Sumitomo Pharmaceuticals Company, Limited Anti-hiv peptide or peptide derivative
FR2694560B1 (fr) * 1992-08-10 1995-06-30 Zagury Jean Francois Nouveaux peptides viraux, anticorps diriges contre ces peptides, procede de preparation, application a titre de medicaments, compositions pharmaceutiques et kits de diagnostic les renfermant.
FR2694938B1 (fr) * 1992-08-10 1996-11-15 Zagury Jean Francois Nouveaux peptides, anticorps diriges contre ces peptides, anticorps anti-idiotypiques, application a titre de medicaments, compositions pharmaceutiques et kits de diagnostic les renfermant.
US5589458A (en) * 1992-11-13 1996-12-31 Thomas Jefferson University Compounds that inhibit T cell proliferation and methods for using the same
DE4447484C2 (de) * 1994-04-08 1997-07-17 Deutsches Krebsforsch Mittel zur Hemmung von Apoptose
US5968753A (en) * 1994-06-14 1999-10-19 Nexell Therapeutics, Inc. Positive and positive/negative cell selection mediated by peptide release
EP1460088A1 (en) 2003-03-21 2004-09-22 Biotest AG Humanized anti-CD4 antibody with immunosuppressive properties
BRPI0909179A2 (pt) 2008-03-13 2015-08-25 Biotest Ag Composição farmacêutica, e, método de tratamento de uma doença autoimune.
WO2009121690A1 (en) 2008-03-13 2009-10-08 Biotest Ag Agent for treating disease
ES2569217T3 (es) 2008-03-13 2016-05-09 Biotest Ag Agente para tratar enfermedades
GB0920944D0 (en) 2009-11-30 2010-01-13 Biotest Ag Agents for treating disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987005935A1 (en) * 1986-04-04 1987-10-08 Battelle Memorial Institute At Columbus, Ohio Gene Methods and compositions for expression of competent eukaryotic gene products
PT88783B (pt) * 1987-10-23 1993-01-29 Smithkline Beckman Corp Processo de purificacao de proteina t4 soluvel e de producao da mesma

Also Published As

Publication number Publication date
DK258789A (da) 1989-11-28
JPH02131497A (ja) 1990-05-21
AU3526689A (en) 1989-11-30
ZA894024B (en) 1991-01-30
EP0344006A3 (en) 1990-08-16
PT90657B (pt) 1995-03-01
EP0344006A2 (en) 1989-11-29
AU626865B2 (en) 1992-08-13
PT90657A (pt) 1989-11-30

Similar Documents

Publication Publication Date Title
DK258789D0 (da) Peptider, der blokerer bindingen af hiv-1 til cd4 receptorproteinet
DK2691D0 (da) Peptider, der binder retroviral protease
DK74387A (da) Sammenfoejningsorgan til sammenfoejning af traebjaelker
DK22387A (da) Fremgangsmaade til fremstilling af ethanol
DK434987A (da) Fremgangsmaade til fremstilling af polypeptider
NO890774D0 (no) Ekspresjon av hiv-bindende proteiner.
DE69028783D1 (de) Künstliche peptide, die die zellbindung steigern
DK495089A (da) Anvendelse af thromboxan a2-receptor-antagonister til fremstilling af laegemidler
DK489683D0 (da) Fremgangsmade til fremstilling af peptider
DK68784A (da) Kontinuert fremgangsmaade til fremstilling af 5-oxo-2,4-dichlor-4-substituerede pentannitriler
DK34888D0 (da) Fremgangsmaade til fremstilling af n,n-(dibenzohexatrienylen)urinstoffer
DK19889A (da) Fremgangsmaade til fremstilling af polypeptider
DE3787927D1 (de) Kleine Peptide, die die Bindung an T-4-Rezeptoren inhibieren und als Immunogene wirken.
DK1019500T3 (da) IFN receptor 1-bindende proteiner, DNA, som koder for dem, og fremgangsmåder til modulering af cellulært respons på interferoner
MA21633A1 (fr) Sunthese peptidiques en phase solide.
DK223188D0 (da) Fremgangsmaade til fremstilling af l-phenylalanin ved hjaelp af rekombinante bakterier
NO895235D0 (no) Syntetiske peptider beslektet med hiv-env-proteiner.
NO910053D0 (no) Retrovirusprotease-bindende peptider.
NO880446D0 (no) Smaa peptider som inhiberer binding til t-4-reseptorer.
NO920318D0 (no) Retrovirusprotease-bindende peptider
NO920319D0 (no) Retrovirusprotease-bindende peptider
DK664089A (da) Fremgangsmaade til fremstilling af l-alanin
DK52188A (da) Smaa peptider, som inhiberer binding til t4-receptorer
DK460987D0 (da) Fremstilling af proteiner.
DK636887A (da) Fremgangsmaade til fremstilling af 17aalfa-hydroxy-d-homo-1,4-pregnadien-3,20-dion

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment